Carnegie Investment Counsel’s Xylem XYL Stock Holding History

Carnegie Investment Counsel’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,884	Closed	-$233K	–	518
2021 Q3	$233K	Sell	1,884 -115	-6%	-$14.8K	0.01%	436
2021 Q2	$240K	Sell	1,999 -283	-12%	-$32.3K	0.01%	433
2021 Q1	$240K	Sell	2,282 -3,189	-58%	-$323K	0.01%	412
2020 Q4	$557K	Buy	5,471 +1	+0%	+$94	0.03%	287
2020 Q3	$460K	Sell	5,470 -1,000	-15%	-$77.8K	0.02%	296
2020 Q2	$420K	Sell	6,470 -14,573	-69%	-$962K	0.02%	301
2020 Q1	$1.37M	Buy	21,043 +6,413	+44%	+$505K	0.1%	172
2019 Q4	$1.15M	Buy	14,630 +1,378	+10%	+$107K	0.07%	211
2019 Q3	$1.05M	Buy	13,252 +8,994	+211%	+$707K	0.07%	214
2019 Q2	$356K	Buy	+4,258	New	+$339K	0.02%	347

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Carnegie Investment Counsel's XYL Position: Q4 2021 in Review

Carnegie Investment Counsel sold out of Xylem (XYL) in Q4 2021, closing a stake of 1,884 shares — an estimated $233K sold.

Carnegie Investment Counsel first reported a position in XYL in Q2 2019 and held it in 10 quarters. The position peaked at $1.37M in Q1 2020. 827 funds tracked by Wall St. Rank hold XYL as of Q4 2021.

Carnegie Investment Counsel reported no remaining Xylem position as of Q4 2021 after selling out during the quarter.
Carnegie Investment Counsel sold 1,884 Xylem shares in Q4 2021, an estimated $233K.
Carnegie Investment Counsel first reported a position in Xylem in Q2 2019 and held it in 10 quarters.
Carnegie Investment Counsel's Xylem position peaked at $1.37M in Q1 2020.
827 funds tracked by Wall St. Rank held Xylem as of Q4 2021.

Based on Carnegie Investment Counsel's 13F filing for Q4 2021, filed 21 Jan 2022.